High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer.

Charles W Ashley Pier Selenica Juber Patel Michelle Wu Josip Nincevic Yulia Lakhman Qin C Zhou Ronak H Shah Michael F Berger Arnaud Da Cruz Paula David N Brown Antonio Marra Alexia E Iasonos Amir Momeni Boroujeni Kaled M Alektiar Kara Long Roche Oliver Zivanovic Jennifer J Mueller Dmitriy Zamarin Vance A Broach Yukio Sonoda Mario L Leitao Claire F Friedman Elizabeth L Jewell Jorge Sergio Reis-Filho Lora H Ellenson Carol Aghajanian Nadeem R Abu-Rustum Karen A Cadoo Jorge S Reis-Filho

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

cfDNA sequencing analysis in EC patients at diagnosis has prognostic value and serial post-surgery cfDNA analysis enables disease and treatment response monitoring.

Keyphrases

coronary artery bypass
percutaneous coronary intervention
endometrial cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
acute coronary syndrome
prognostic factors
peritoneal dialysis
single cell
minimally invasive
patient reported